Shilpita Karmakar has been discussing the FDA-approved stem cell therapies that have been heavily used for therapeutic approaches towards better survival and health span. In the current approach, she is ready to dive into a broader aspect of advancements in technology that have resulted in better treatment strategies under the name of “Bench to Bedside”. This column will expand the bandwidth of knowledge and information about the advancements in technologies, their use for therapeutic interventions, FDA approval, clinical trials, marketing, and application. This will also open up venues for the introduction of new methods used to discover modern FDA-approved drugs, better devices for clinical diagnosis and research practices, and research technologies that have revolutionized health care, like CRISPR and Organoids. “Bench to Bedside” column will serve as a strategic platform to bring together the diverse scientific research, clinical approach, technological innovations, AI-driven approaches, and public health under a unified umbrella, aiming to bridge the gap between laboratory research and real-world healthcare.
(Click anywhere on the image to expand)
Disclaimer
The editors take care to share authentic information. In case of any discrepancies please write to newsletter@medness.org.
The sponsors do not have any influence on the nature or kind of the news/analysis reported in MedNess. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of MedNess. Examples of analysis performed within this article are only examples. They should not be utilized in real-world analytic products as they are based only on very limited and dated open-source information. Assumptions made within the analysis are not reflective of the position of anyone volunteering or working for MedNess. This blog is strictly for news and information. It does not provide medical advice, diagnosis or treatment nor investment suggestions. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or another qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.
MedNess is a part of STEMPeers® which is a 501(c)(3) organization registered in PA as PhD Career Support Group. The organization helps create a growing network of STEM scientists that is involved in peer-to-peer mentoring and support.
